Csenge Advisory Group’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
27,149
+2,402
| +10% | +$98.6K | 0.06% | 248 |
|
|
2025
Q1 | $889K | Buy |
24,747
+4,606
| +23% | +$165K | 0.05% | 274 |
|
|
2024
Q4 | $681K | Buy |
20,141
+2,423
| +14% | +$81.9K | 0.04% | 355 |
|
|
2024
Q3 | $688K | Sell |
17,718
-2,645
| -13% | -$103K | 0.04% | 357 |
|
|
2024
Q2 | $784K | Buy |
20,363
+1,236
| +6% | +$47.6K | 0.04% | 302 |
|
|
2024
Q1 | $820K | Buy |
19,127
+3,271
| +21% | +$140K | 0.05% | 310 |
|
|
2023
Q4 | $588K | Buy |
15,856
+9,414
| +146% | +$349K | 0.04% | 363 |
|
|
2023
Q3 | $234K | Buy |
6,442
+609
| +10% | +$22.1K | 0.02% | 548 |
|
|
2023
Q2 | $208K | Sell |
5,833
-311
| -5% | -$11.1K | 0.01% | 600 |
|
|
2023
Q1 | $219K | Sell |
6,144
-279
| -4% | -$9.93K | 0.02% | 538 |
|
|
2022
Q4 | $226K | Sell |
6,423
-1,170
| -15% | -$41.1K | 0.02% | 536 |
|
|
2022
Q3 | $223K | Buy |
7,593
+1,513
| +25% | +$44.4K | 0.02% | 537 |
|
|
2022
Q2 | $331K | Hold |
6,080
| – | – | 0.03% | 427 |
|
|
2022
Q1 | $331K | Buy |
+6,080
| New | +$331K | 0.03% | 473 |
|
|
2018
Q4 | – | Sell |
-3,714
| Closed | -$189K | – | 699 |
|
|
2018
Q3 | $189K | Buy |
+3,714
| New | +$189K | 0.07% | 166 |
|